» Articles » PMID: 16047111

Corticospinal Involvement in Patients with a Portosystemic Shunt Due to Liver Cirrhosis: a MEP Study

Overview
Journal J Neurol
Specialty Neurology
Date 2005 Jul 28
PMID 16047111
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic myelopathy (HM) is a rare complication of chronic liver diseases usually associated with a portosystemic shunt, causing a progressive spastic paraparesis, and is likely to be overlooked. Thirteen patients with liver cirrhosis associated with surgical or spontaneous portosystemic shunts were studied to determine the frequency and gravity of HM. Six patients exhibited clear-cut signs of spinal cord involvement and four of them exhibited varying degrees of disability. Neurological examination did not reveal any abnormalities in the other patients. Motor evoked potentials (MEPs) were measured in all patients; in five of them the examinations were done before and after orthotopic liver transplantation (OLT). The patients with clinical signs of spinal cord involvement exhibited severe neurophysiological abnormalities, whereas milder but unequivocal MEP abnormalities were found in four of the seven patients with normal clinical examination. The clinical and neurophysiological features of patients with slight MEP abnormalities improved after OLT, whereas the patients with a more advanced stage of disease (severe MEPs abnormalities) did not. Our findings indicate that MEP studies may disclose an impairment of the corticospinal pathways even before HM is clinically manifest and provide evidence that early diagnosis of HM and subsequent immediate liver transplantation have to be recommended.

Citing Articles

Hepatic myelopathy neurological complication of chronic liver disease: two case reports.

Mhiri M, Ben Abdelwahed M, Dhiflaoui M, Ben Dhia R, Gouta N, Jemni I J Med Case Rep. 2024; 18(1):281.

PMID: 38880918 PMC: 11181619. DOI: 10.1186/s13256-024-04495-2.


Liver Transplantation Reverses Hepatic Myelopathy in the Decompensated Phase of Cirrhosis: Case Report and Literature Review.

Li J, Wan S, Wen F, Li Q, Cui Y, Lu Z J Clin Transl Hepatol. 2024; 12(4):436-442.

PMID: 38638382 PMC: 11022064. DOI: 10.14218/JCTH.2023.00487.


Spontaneous remission of hepatic myelopathy in a patient with alcoholic cirrhosis: A case report.

Chang C, Liu C, Duan F, Zhai H, Song S, Yang S World J Clin Cases. 2022; 10(30):11172-11177.

PMID: 36338225 PMC: 9631124. DOI: 10.12998/wjcc.v10.i30.11172.


Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study.

Liu K, Chen G, Ren S, Zhu Y, Yu T, Tian P Neural Regen Res. 2019; 14(5):850-857.

PMID: 30688271 PMC: 6375042. DOI: 10.4103/1673-5374.249233.


Spinal Cord Infarction in the Course of a Septic Shock: About One Case and Review of the Literature.

Henin P, Molderez A, Huberlant V, Trine H Case Rep Crit Care. 2017; 2017:1571048.

PMID: 28316845 PMC: 5337840. DOI: 10.1155/2017/1571048.


References
1.
Bain V, Bailey R, Jhamandas J . Postshunt myelopathy. J Clin Gastroenterol. 1991; 13(5):562-4. DOI: 10.1097/00004836-199110000-00018. View

2.
Budillon G, MANSI D, Scala G, Campanella G . "Hepatic paraplegia": an uncommon complication of portosystemic shunt. Acta Neurol (Napoli). 1979; 1(2):93-100. View

3.
Rossini P, Barker A, Berardelli A, Caramia M, Caruso G, Cracco R . Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994; 91(2):79-92. DOI: 10.1016/0013-4694(94)90029-9. View

4.
Drake A, Patterson M . CHRONIC PERMANENT ENCEPHALOMYELOPATHY FOLLOWING PORTAL-SYSTEMIC SHUNTS. South Med J. 1964; 57:617-22. DOI: 10.1097/00007611-196406000-00001. View

5.
McCarthy C, Read A, ROSS F, Wells P . Ultrasonic scanning of the liver. Q J Med. 1967; 36(144):517-24. View